NNBP.US Nanobac Pharmaceuticals Incorporated

Healthcare Biotechnology USA Stocks
- USD
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2007.

Is NNBP.US undervalued?

Graham number

The Graham number of Nanobac Pharmaceuticals Incorporated cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Nanobac Pharmaceuticals Incorporated fundamental analysis

No fundamental analysis for Nanobac Pharmaceuticals Incorporated yet.

Nanobac Pharmaceuticals Incorporated stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Nanobac Pharmaceuticals Incorporated

Nanobac Pharmaceuticals, Incorporated discovers and develops products and services to improve human health through the detection and treatment of calcifying nanoparticles (CNPs). It manufactures and markets in vitro diagnostic (IVD) kits, such as assays, antibodies, and reagents for detecting CNPs. The company's diagnostic assays comprise NANO-CAPTURE and NANO-SERO. Additionally, it conducts research and clinical studies in the development of urological diseases, including c…

Full company profile